Cargando…

The evolution of infrahissian conduction time in myotonic dystrophy patients: clinical implications

BACKGROUND: Myotonic dystrophy (MD1) is a hereditary autosomal dominant disease with variable penetrance. Cardiac conduction disturbances are frequent and may be responsible for sudden death, but its progression was heretofore unknown. AIMS: The aim of the study was to analyse the natural history of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lallemand, Bénédicte, Clementy, Nicolas, Bernard-Brunet, Anne, Pierre, Bertrand, Corcia, Philippe, Fauchier, Laurent, Raynaud, Martine, Pellieux, Sybille, Babuty, Dominique
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Group 2011
Materias:	Heart Rhythm Disorders
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3262987/ https://www.ncbi.nlm.nih.gov/pubmed/22038543 http://dx.doi.org/10.1136/heartjnl-2011-300143

Ejemplares similares

Electrocardiographic predictors of infrahissian conduction disturbances in myotonic dystrophy type 1
por: Joosten, Isis B T, et al.
Publicado: (2020)

Does additional linear ablation after circumferential pulmonary vein isolation improve clinical outcome in patients with paroxysmal atrial fibrillation? Prospective randomised study
por: Mun, Hee-Sun, et al.
Publicado: (2012)

Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in UK patients with atrial fibrillation
por: Kansal, Anuraag R, et al.
Publicado: (2012)

Pulmonary venous isolation by antral ablation with a large cryoballoon for treatment of paroxysmal and persistent atrial fibrillation: medium-term outcomes and non-randomised comparison with pulmonary venous isolation by radiofrequency ablation
por: Kojodjojo, Pipin, et al.
Publicado: (2010)

The use of anticoagulants in the management of atrial fibrillation among general practices in England
por: Cowan, Campbell, et al.
Publicado: (2013)

Myotonic dystrophy presenting as severely dilated cardiomyopathy with out-of-hospital cardiac arrest
por: Isrie, M., et al.
Publicado: (2018)

Leadless or Conventional Transvenous Ventricular Permanent Pacemakers: A Nationwide Matched Control Study
por: Bodin, Alexandre, et al.
Publicado: (2022)

Non-Vitamin K Oral Anticoagulants for Stroke Prevention in Special Populations with Atrial Fibrillation
por: Bisson, Arnaud, et al.
Publicado: (2017)

Benefits of an early management of palpitations
por: Clementy, Nicolas, et al.
Publicado: (2018)

Galectin-3 in Atrial Fibrillation: Mechanisms and Therapeutic Implications
por: Clementy, Nicolas, et al.
Publicado: (2018)

Localization of Left Ventricular Lead Electrodes in Relation to Myocardial Scar in Patients Undergoing Cardiac Resynchronization Therapy
por: Bisson, Arnaud, et al.
Publicado: (2018)

Serum Galectin-3 Levels Predict Recurrences after Ablation of Atrial Fibrillation
por: Clementy, Nicolas, et al.
Publicado: (2016)

Galectin-3 level predicts response to ablation and outcomes in patients with persistent atrial fibrillation and systolic heart failure
por: Clementy, Nicolas, et al.
Publicado: (2018)

Galectin-3 predicts response and outcomes after cardiac resynchronization therapy
por: Andre, Clémentine, et al.
Publicado: (2018)

Successful ‘quadrangular' pacing in a non-responder patient to cardiac resynchronization therapy
por: Clementy, Nicolas, et al.
Publicado: (2011)

Pacemaker Implantation After Balloon‐ or Self‐Expandable Transcatheter Aortic Valve Replacement in Patients With Aortic Stenosis
por: Bisson, Arnaud, et al.
Publicado: (2020)

Myotonic dystrophy
por: Patterson, VH
Publicado: (1990)

Muscle magnetic resonance imaging in myotonic dystrophy type 1 (DM1): Refining muscle involvement and implications for clinical trials
por: Garibaldi, Matteo, et al.
Publicado: (2021)

Shedding light on motor premanifest myotonic dystrophy type 1: A molecular, muscular and central nervous system follow‐up study
por: Garmendia, Joana, et al.
Publicado: (2022)

Cancer and Myotonic Dystrophy
por: D’Ambrosio, Eleonora S., et al.
Publicado: (2023)

Incident Comorbidities, Aging and the Risk of Stroke in 608,108 Patients with Atrial Fibrillation: A Nationwide Analysis
por: Fauchier, Laurent, et al.
Publicado: (2020)

Exploiting metamerism to regulate the impact of a visual display on alertness and melatonin suppression independent of visual appearance
por: Allen, Annette E, et al.
Publicado: (2018)

The evening light environment in hospitals can be designed to produce less disruptive effects on the circadian system and improve sleep
por: Vethe, Daniel, et al.
Publicado: (2020)

Evening-types show highest increase of sleep and mental health problems during the COVID-19 pandemic—multinational study on 19 267 adults
por: Merikanto, Ilona, et al.
Publicado: (2021)

Greatest changes in objective sleep architecture during COVID-19 lockdown in night owls with increased REM sleep
por: Pépin, Jean-Louis, et al.
Publicado: (2021)

Workshop report. Circadian rhythm sleep–wake disorders: gaps and opportunities
por: Duffy, Jeanne F, et al.
Publicado: (2021)

Evening chronotype is associated with elevated biomarkers of cardiometabolic risk in the EpiHealth cohort: a cross-sectional study
por: Baldanzi, Gabriel, et al.
Publicado: (2021)

Validation of blood-based transcriptomic circadian phenotyping in older adults
por: Smith, S Kendall, et al.
Publicado: (2022)

From dawn to dusk—mimicking natural daylight exposure improves circadian rhythm entrainment in patients with severe brain injury
por: Angerer, Monika, et al.
Publicado: (2022)

Genome-wide gene by environment study of time spent in daylight and chronotype identifies emerging genetic architecture underlying light sensitivity
por: Burns, Angus C, et al.
Publicado: (2022)

The dim light melatonin onset across ages, methodologies, and sex and its relationship with morningness/eveningness
por: Kennaway, David J
Publicado: (2023)

Measuring light regularity: sleep regularity is associated with regularity of light exposure in adolescents
por: Hand, Anthony J, et al.
Publicado: (2023)

Population-representative study reveals cardiovascular and metabolic disease biomarkers associated with misaligned sleep schedules
por: Sládek, Martin, et al.
Publicado: (2023)

Cardiac Conduction Disorders as Markers of Cardiac Events in Myotonic Dystrophy Type 1
por: Itoh, Hideki, et al.
Publicado: (2020)

Desflurane anaesthesia in myotonic dystrophy
por: Gandhi, Ranju, et al.
Publicado: (2011)

Myotonic Dystrophy: An Anaesthetic Dilemma
por: Gupta, N, et al.
Publicado: (2009)

Cardiac involvement in myotonic dystrophy
por: Khalighi, Koroush, et al.
Publicado: (2015)

Steakhouse Syndrome in Myotonic Dystrophy
por: Ogasawara, Nobuhiko, et al.
Publicado: (2017)

Cutaneous findings in myotonic dystrophy
por: Kong, Ha Eun, et al.
Publicado: (2022)

Cardiac Manifestations of Myotonic Dystrophy in a Pediatric Cohort
por: Brunet Garcia, Laia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5pjgf0318fls87obfm6evj0ujf